House Panel To Review Express Scripts' $29B Medco Buy
The House Judiciary subcommittee on intellectual property, competition and the Internet is scheduled to review the transaction that aims to combine the largest and third-largest pharmacy benefits managers.
The subcommittee's website has not yet posted a list of witnesses for the hearing. Representatives for the companies were not...
To view the full article, register now.